Rossari Biotech Limited (ROSSARI) - Total Liabilities

Latest as of September 2025: Rs8.36 Billion INR ≈ $90.46 Million USD

Based on the latest financial reports, Rossari Biotech Limited (ROSSARI) has total liabilities worth Rs8.36 Billion INR (≈ $90.46 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check Rossari Biotech Limited liquidity resilience to evaluate the company's liquid asset resilience ratio.

Rossari Biotech Limited - Total Liabilities Trend (2017–2025)

This chart illustrates how Rossari Biotech Limited's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see balance sheet size of Rossari Biotech Limited.

Rossari Biotech Limited Competitors by Total Liabilities

The table below lists competitors of Rossari Biotech Limited ranked by their total liabilities.

Company	Country	Total Liabilities
Ningbo GQY Video Telecom SHE:300076	China	CN¥124.40 Million
Bonduelle S.C.A. PA:BON	France	€1.47 Billion
MEDI ASSIST HEALTHCARE SERVICES LIMITED NSE:MEDIASSIST	India	Rs-8.52 Billion
HomeStreet Inc NASDAQ:HMST	USA	$7.21 Billion
Drugs Made In America Acquisition Corp. Ordinary Shares NASDAQ:DMAA	USA	$9.14 Million
Jiangsu Jingyuan Environmental Protection Co Ltd SHG:688096	China	CN¥1.07 Billion
Agora Inc NASDAQ:API	USA	$176.56 Million
Pruksa Holding Public Company Limited BK:PSH	Thailand	฿19.02 Billion

Liability Composition Analysis (2017–2025)

This chart breaks down Rossari Biotech Limited's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See ROSSARI equity to assets ratio to measure how much of total assets are equity-financed.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	1.73	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.67	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.40	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Rossari Biotech Limited's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Rossari Biotech Limited (2017–2025)

The table below shows the annual total liabilities of Rossari Biotech Limited from 2017 to 2025.

Year	Total Liabilities	Change
2025-03-31	Rs7.11 Billion ≈ $76.86 Million	+35.53%
2024-03-31	Rs5.24 Billion ≈ $56.71 Million	+15.92%
2023-03-31	Rs4.52 Billion ≈ $48.93 Million	+0.19%
2022-03-31	Rs4.52 Billion ≈ $48.83 Million	+195.96%
2021-03-31	Rs1.53 Billion ≈ $16.50 Million	-17.45%
2020-03-31	Rs1.85 Billion ≈ $19.99 Million	+46.66%
2019-03-31	Rs1.26 Billion ≈ $13.63 Million	+61.85%
2018-03-31	Rs778.70 Million ≈ $8.42 Million	+13.00%
2017-03-31	Rs689.09 Million ≈ $7.45 Million	--

About Rossari Biotech Limited

NSE:ROSSARI India Specialty Chemicals

Market Cap

$262.30 Million

Rs24.25 Billion INR

Market Cap Rank

#15551 Global

#778 in India

Share Price

Rs437.95

Change (1 day)

-0.64%

52-Week Range

Rs378.60 - Rs672.55

All Time High

Rs1568.62